<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cialis (Tadalafil) Drug description &#187; Main</title>
	<atom:link href="http://www.cialis-database.com/category/main/feed" rel="self" type="application/rss+xml" />
	<link>http://www.cialis-database.com</link>
	<description>Cialis (tadalafil) used to treat erectile dysfunction</description>
	<lastBuildDate>Sat, 12 Sep 2009 13:44:14 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.3</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>History of the development of tadalafil</title>
		<link>http://www.cialis-database.com/main/history-of-the-development-of-tadalafil.html</link>
		<comments>http://www.cialis-database.com/main/history-of-the-development-of-tadalafil.html#comments</comments>
		<pubDate>Thu, 23 Jul 2009 16:16:34 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Eli Lilly]]></category>
		<category><![CDATA[History]]></category>
		<category><![CDATA[sildenafil]]></category>
		<category><![CDATA[tadalafil]]></category>

		<guid isPermaLink="false">http://www.cialis-database.com/?p=117</guid>
		<description><![CDATA[The Bothell, Washington-based pharmacologic research company ICOS Corporation was started in 1990, and it began the initial cardiovascular testing of a PDE5 inhibitor called IC351 in 1993. Meanwhile, sildenafil citrate (sildenafil) was discovered to cause improved erectile function as a side effect in a trial testing its efficacy for the treatment of angina pectoris in [...]]]></description>
		<wfw:commentRss>http://www.cialis-database.com/main/history-of-the-development-of-tadalafil.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Treatment strategies and effect on sexual behavior</title>
		<link>http://www.cialis-database.com/main/treatment-strategies-and-effect-on-sexual-behavior.html</link>
		<comments>http://www.cialis-database.com/main/treatment-strategies-and-effect-on-sexual-behavior.html#comments</comments>
		<pubDate>Wed, 01 Jul 2009 13:38:42 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[ED]]></category>
		<category><![CDATA[tadalafil]]></category>

		<guid isPermaLink="false">http://www.cialis-database.com/?p=112</guid>
		<description><![CDATA[
Although efficacy and safety are two important characteristics when choosing a pharmacological treatment for ED, the ideal therapy should be reliable during maintenance. Furthermore, beyond erection and penetration, intercourse success and overall satisfaction needs have to be considered. The primary goal in the treatment of ED should be the restoration of sexual life rather than [...]]]></description>
		<wfw:commentRss>http://www.cialis-database.com/main/treatment-strategies-and-effect-on-sexual-behavior.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The clinical evidence: safety of tadalafil in ED</title>
		<link>http://www.cialis-database.com/main/the-clinical-evidence-safety-of-tadalafil-in-ed.html</link>
		<comments>http://www.cialis-database.com/main/the-clinical-evidence-safety-of-tadalafil-in-ed.html#comments</comments>
		<pubDate>Sun, 14 Jun 2009 18:53:15 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[ED]]></category>
		<category><![CDATA[tadalafil]]></category>

		<guid isPermaLink="false">http://www.cialis-database.com/?p=109</guid>
		<description><![CDATA[Most of the side effects reported in the clinical trials are dose-dependent and consistent with the vasodilatatory effect of PDE-5 inhibition. When tadalafil (Cialis) was administered on an on-demand basis headache and dyspepsia were the most frequent symptoms, followed by back pain, nasal congestion, myalgia, and flushing. Subgroup analyses have revealed no differences between incidences [...]]]></description>
		<wfw:commentRss>http://www.cialis-database.com/main/the-clinical-evidence-safety-of-tadalafil-in-ed.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The clinical evidence: efficacy of tadalafil in ED</title>
		<link>http://www.cialis-database.com/main/the-clinical-evidence-efficacy-of-tadalafil-in-ed.html</link>
		<comments>http://www.cialis-database.com/main/the-clinical-evidence-efficacy-of-tadalafil-in-ed.html#comments</comments>
		<pubDate>Fri, 15 May 2009 13:24:28 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[ED]]></category>
		<category><![CDATA[tadalafil]]></category>

		<guid isPermaLink="false">http://www.cialis-database.com/?p=103</guid>
		<description><![CDATA[
The most important outcome for an ED therapy is the patient’s perception of success. When patients with ED experience a successful intercourse after treatment, they feel cured of their problem. Furthermore, they express the desire of unplanned, unpremeditated or spontaneous sexual intercourse. In this sense, one possible use of the self-administered questionnaire International Index of [...]]]></description>
		<wfw:commentRss>http://www.cialis-database.com/main/the-clinical-evidence-efficacy-of-tadalafil-in-ed.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A clinical pharmacological approach to the effective and safe use of tadalafil</title>
		<link>http://www.cialis-database.com/main/a-clinical-pharmacological-approach-to-the-effective-and-safe-use-of-tadalafil.html</link>
		<comments>http://www.cialis-database.com/main/a-clinical-pharmacological-approach-to-the-effective-and-safe-use-of-tadalafil.html#comments</comments>
		<pubDate>Mon, 06 Apr 2009 15:11:33 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[cGMP]]></category>
		<category><![CDATA[tadalafil]]></category>

		<guid isPermaLink="false">http://www.cialis-database.com/?p=100</guid>
		<description><![CDATA[The mechanism of action leading to penile erection involves inhibition of PDE5, the major cyclic guanosine monophospate (cGMP) hydrolyzing enzyme located in the vascular smooth muscle cells of corpus cavernosum. Sexual stimulation triggers the release of the endothelium dependent relaxing factor nitric oxide (NO), stimulating through the protein kinase G the release of guanylyl cyclase [...]]]></description>
		<wfw:commentRss>http://www.cialis-database.com/main/a-clinical-pharmacological-approach-to-the-effective-and-safe-use-of-tadalafil.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
